BENZOCYCLOALKYL AZOLOTHIONE DERIVATIVES

The present invention relates to novel benzocycloalkylazolethione compounds of formula (I) in which n is 0, 1 or 2; t is 0, 1, 2 or 3; R is independently halo, hydroxy or (C1-4)alkyloxy; and R is attached to the alpha , beta or gamma -position and is a group selected from formulae (a), (b) and (c) w...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	BANSAL REKHA P, REPKE DAVID B, TEITELBAUM PHILIP J, GOODING OWEN W, MUEHLDORF ALEXANDER V, WALKER KEITH A.M, O'YANG COUNDE, MARTINEZ GREGORY R, WHITING ROGER L
Format:	Patent
Sprache:	eng ; pol
Schlagworte:	ACYCLIC OR CARBOCYCLIC COMPOUNDS APPARATUS THEREFOR CHEMISTRY GENERAL METHODS OF ORGANIC CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

container_end_page
container_issue
container_start_page
container_title
container_volume
creator	BANSAL REKHA P REPKE DAVID B TEITELBAUM PHILIP J GOODING OWEN W MUEHLDORF ALEXANDER V WALKER KEITH A.M O'YANG COUNDE MARTINEZ GREGORY R WHITING ROGER L
description	The present invention relates to novel benzocycloalkylazolethione compounds of formula (I) in which n is 0, 1 or 2; t is 0, 1, 2 or 3; R is independently halo, hydroxy or (C1-4)alkyloxy; and R is attached to the alpha , beta or gamma -position and is a group selected from formulae (a), (b) and (c) which are dopamine beta -hydroxylase inhibitors in which the benzocycloalkyl portion of the compound is selected from indanyl, 1,2,3,4-tetrahydronaphthalenyl and 6,7,8,9-tetrahydro-5H-benzocycloheptenyl (in which the benzo is optionally substituted with one to three substituents) and the azolethione portion of the compound is selected from 2-thioxo-2,3-dihydro-1H-imidazol-3-yl, 5-thioxo-4,5-dihydro-1H-[1,2,4]triazol-4-yl and 5-thioxo-4,5-dihydro-1H-[1,2,4]triazol-1-yl (each optionally substituted with one to three substituents); and the prodrugs, pharmaceutically acceptable salts, individual isomers and mixtures of isomers and the methods of using and preparing such benzocycloalkylazolethione compounds.
format	Patent
fullrecord	<record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_PL185959BB1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>PL185959BB1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_PL185959BB13</originalsourceid><addsrcrecordid>eNrjZFB3cvWL8neOdPbxd_TxjvRRcIzy9_EP8fD093NVcHEN8gxzDPEMcw3mYWBNS8wpTuWF0twMCm6uIc4euqkF-fGpxQWJyal5qSXxAT6GFqaWppZOTobGRCgBAOAZJDs</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>BENZOCYCLOALKYL AZOLOTHIONE DERIVATIVES</title><source>esp@cenet</source><creator>BANSAL REKHA P ; REPKE DAVID B ; TEITELBAUM PHILIP J ; GOODING OWEN W ; MUEHLDORF ALEXANDER V ; WALKER KEITH A.M ; O'YANG COUNDE ; MARTINEZ GREGORY R ; WHITING ROGER L</creator><creatorcontrib>BANSAL REKHA P ; REPKE DAVID B ; TEITELBAUM PHILIP J ; GOODING OWEN W ; MUEHLDORF ALEXANDER V ; WALKER KEITH A.M ; O'YANG COUNDE ; MARTINEZ GREGORY R ; WHITING ROGER L</creatorcontrib><description>The present invention relates to novel benzocycloalkylazolethione compounds of formula (I) in which n is 0, 1 or 2; t is 0, 1, 2 or 3; R is independently halo, hydroxy or (C1-4)alkyloxy; and R is attached to the alpha , beta or gamma -position and is a group selected from formulae (a), (b) and (c) which are dopamine beta -hydroxylase inhibitors in which the benzocycloalkyl portion of the compound is selected from indanyl, 1,2,3,4-tetrahydronaphthalenyl and 6,7,8,9-tetrahydro-5H-benzocycloheptenyl (in which the benzo is optionally substituted with one to three substituents) and the azolethione portion of the compound is selected from 2-thioxo-2,3-dihydro-1H-imidazol-3-yl, 5-thioxo-4,5-dihydro-1H-[1,2,4]triazol-4-yl and 5-thioxo-4,5-dihydro-1H-[1,2,4]triazol-1-yl (each optionally substituted with one to three substituents); and the prodrugs, pharmaceutically acceptable salts, individual isomers and mixtures of isomers and the methods of using and preparing such benzocycloalkylazolethione compounds.</description><edition>7</edition><language>eng ; pol</language><subject>ACYCLIC OR CARBOCYCLIC COMPOUNDS ; APPARATUS THEREFOR ; CHEMISTRY ; GENERAL METHODS OF ORGANIC CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2003</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20030930&DB=EPODOC&CC=PL&NR=185959B1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25543,76293</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20030930&DB=EPODOC&CC=PL&NR=185959B1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>BANSAL REKHA P</creatorcontrib><creatorcontrib>REPKE DAVID B</creatorcontrib><creatorcontrib>TEITELBAUM PHILIP J</creatorcontrib><creatorcontrib>GOODING OWEN W</creatorcontrib><creatorcontrib>MUEHLDORF ALEXANDER V</creatorcontrib><creatorcontrib>WALKER KEITH A.M</creatorcontrib><creatorcontrib>O'YANG COUNDE</creatorcontrib><creatorcontrib>MARTINEZ GREGORY R</creatorcontrib><creatorcontrib>WHITING ROGER L</creatorcontrib><title>BENZOCYCLOALKYL AZOLOTHIONE DERIVATIVES</title><description>The present invention relates to novel benzocycloalkylazolethione compounds of formula (I) in which n is 0, 1 or 2; t is 0, 1, 2 or 3; R is independently halo, hydroxy or (C1-4)alkyloxy; and R is attached to the alpha , beta or gamma -position and is a group selected from formulae (a), (b) and (c) which are dopamine beta -hydroxylase inhibitors in which the benzocycloalkyl portion of the compound is selected from indanyl, 1,2,3,4-tetrahydronaphthalenyl and 6,7,8,9-tetrahydro-5H-benzocycloheptenyl (in which the benzo is optionally substituted with one to three substituents) and the azolethione portion of the compound is selected from 2-thioxo-2,3-dihydro-1H-imidazol-3-yl, 5-thioxo-4,5-dihydro-1H-[1,2,4]triazol-4-yl and 5-thioxo-4,5-dihydro-1H-[1,2,4]triazol-1-yl (each optionally substituted with one to three substituents); and the prodrugs, pharmaceutically acceptable salts, individual isomers and mixtures of isomers and the methods of using and preparing such benzocycloalkylazolethione compounds.</description><subject>ACYCLIC OR CARBOCYCLIC COMPOUNDS</subject><subject>APPARATUS THEREFOR</subject><subject>CHEMISTRY</subject><subject>GENERAL METHODS OF ORGANIC CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2003</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZFB3cvWL8neOdPbxd_TxjvRRcIzy9_EP8fD093NVcHEN8gxzDPEMcw3mYWBNS8wpTuWF0twMCm6uIc4euqkF-fGpxQWJyal5qSXxAT6GFqaWppZOTobGRCgBAOAZJDs</recordid><startdate>20030930</startdate><enddate>20030930</enddate><creator>BANSAL REKHA P</creator><creator>REPKE DAVID B</creator><creator>TEITELBAUM PHILIP J</creator><creator>GOODING OWEN W</creator><creator>MUEHLDORF ALEXANDER V</creator><creator>WALKER KEITH A.M</creator><creator>O'YANG COUNDE</creator><creator>MARTINEZ GREGORY R</creator><creator>WHITING ROGER L</creator><scope>EVB</scope></search><sort><creationdate>20030930</creationdate><title>BENZOCYCLOALKYL AZOLOTHIONE DERIVATIVES</title><author>BANSAL REKHA P ; REPKE DAVID B ; TEITELBAUM PHILIP J ; GOODING OWEN W ; MUEHLDORF ALEXANDER V ; WALKER KEITH A.M ; O'YANG COUNDE ; MARTINEZ GREGORY R ; WHITING ROGER L</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_PL185959BB13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; pol</language><creationdate>2003</creationdate><topic>ACYCLIC OR CARBOCYCLIC COMPOUNDS</topic><topic>APPARATUS THEREFOR</topic><topic>CHEMISTRY</topic><topic>GENERAL METHODS OF ORGANIC CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>BANSAL REKHA P</creatorcontrib><creatorcontrib>REPKE DAVID B</creatorcontrib><creatorcontrib>TEITELBAUM PHILIP J</creatorcontrib><creatorcontrib>GOODING OWEN W</creatorcontrib><creatorcontrib>MUEHLDORF ALEXANDER V</creatorcontrib><creatorcontrib>WALKER KEITH A.M</creatorcontrib><creatorcontrib>O'YANG COUNDE</creatorcontrib><creatorcontrib>MARTINEZ GREGORY R</creatorcontrib><creatorcontrib>WHITING ROGER L</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>BANSAL REKHA P</au><au>REPKE DAVID B</au><au>TEITELBAUM PHILIP J</au><au>GOODING OWEN W</au><au>MUEHLDORF ALEXANDER V</au><au>WALKER KEITH A.M</au><au>O'YANG COUNDE</au><au>MARTINEZ GREGORY R</au><au>WHITING ROGER L</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>BENZOCYCLOALKYL AZOLOTHIONE DERIVATIVES</title><date>2003-09-30</date><risdate>2003</risdate><abstract>The present invention relates to novel benzocycloalkylazolethione compounds of formula (I) in which n is 0, 1 or 2; t is 0, 1, 2 or 3; R is independently halo, hydroxy or (C1-4)alkyloxy; and R is attached to the alpha , beta or gamma -position and is a group selected from formulae (a), (b) and (c) which are dopamine beta -hydroxylase inhibitors in which the benzocycloalkyl portion of the compound is selected from indanyl, 1,2,3,4-tetrahydronaphthalenyl and 6,7,8,9-tetrahydro-5H-benzocycloheptenyl (in which the benzo is optionally substituted with one to three substituents) and the azolethione portion of the compound is selected from 2-thioxo-2,3-dihydro-1H-imidazol-3-yl, 5-thioxo-4,5-dihydro-1H-[1,2,4]triazol-4-yl and 5-thioxo-4,5-dihydro-1H-[1,2,4]triazol-1-yl (each optionally substituted with one to three substituents); and the prodrugs, pharmaceutically acceptable salts, individual isomers and mixtures of isomers and the methods of using and preparing such benzocycloalkylazolethione compounds.</abstract><edition>7</edition><oa>free_for_read</oa></addata></record>
fulltext	fulltext_linktorsrc
identifier
ispartof
issn
language	eng ; pol
recordid	cdi_epo_espacenet_PL185959BB1
source	esp@cenet
subjects	ACYCLIC OR CARBOCYCLIC COMPOUNDS APPARATUS THEREFOR CHEMISTRY GENERAL METHODS OF ORGANIC CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title	BENZOCYCLOALKYL AZOLOTHIONE DERIVATIVES
url	https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T02%3A02%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=BANSAL%20REKHA%20P&rft.date=2003-09-30&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EPL185959BB1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true